Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Clinical trial NCT02875613 · TERMINATED
Trial details
- NCT number
- NCT02875613
- Sponsor
- Assuntina Sacco, M.D.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.